nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—ADRA1B—vas deferens—urinary bladder cancer	0.176	0.397	CbGeAlD
Lisuride—HTR2A—urine—urinary bladder cancer	0.0159	0.0359	CbGeAlD
Lisuride—ADRA1D—prostate gland—urinary bladder cancer	0.0153	0.0347	CbGeAlD
Lisuride—CYP3A4—urine—urinary bladder cancer	0.0147	0.0332	CbGeAlD
Lisuride—CYP2D6—urine—urinary bladder cancer	0.0145	0.0327	CbGeAlD
Lisuride—Pulmonary fibrosis—Gemcitabine—urinary bladder cancer	0.0136	0.0244	CcSEcCtD
Lisuride—Pericarditis—Fluorouracil—urinary bladder cancer	0.0136	0.0244	CcSEcCtD
Lisuride—Pleurisy—Methotrexate—urinary bladder cancer	0.0126	0.0225	CcSEcCtD
Lisuride—Pulmonary fibrosis—Etoposide—urinary bladder cancer	0.0116	0.0209	CcSEcCtD
Lisuride—ADRA1D—epithelium—urinary bladder cancer	0.0113	0.0255	CbGeAlD
Lisuride—ADRB1—prostate gland—urinary bladder cancer	0.0111	0.0252	CbGeAlD
Lisuride—ADRA1B—renal system—urinary bladder cancer	0.0107	0.0242	CbGeAlD
Lisuride—DRD5—female reproductive system—urinary bladder cancer	0.0104	0.0236	CbGeAlD
Lisuride—ADRA1D—urethra—urinary bladder cancer	0.0103	0.0232	CbGeAlD
Lisuride—Oedema peripheral—Valrubicin—urinary bladder cancer	0.0102	0.0182	CcSEcCtD
Lisuride—ADRA2C—prostate gland—urinary bladder cancer	0.0084	0.019	CbGeAlD
Lisuride—ADRA1D—female reproductive system—urinary bladder cancer	0.00838	0.0189	CbGeAlD
Lisuride—Pleural effusion—Gemcitabine—urinary bladder cancer	0.00783	0.014	CcSEcCtD
Lisuride—HTR2B—smooth muscle tissue—urinary bladder cancer	0.00755	0.0171	CbGeAlD
Lisuride—Pericardial effusion—Methotrexate—urinary bladder cancer	0.00747	0.0134	CcSEcCtD
Lisuride—Dementia—Methotrexate—urinary bladder cancer	0.00747	0.0134	CcSEcCtD
Lisuride—ADRA2C—seminal vesicle—urinary bladder cancer	0.0071	0.0161	CbGeAlD
Lisuride—Pericarditis—Methotrexate—urinary bladder cancer	0.00709	0.0127	CcSEcCtD
Lisuride—Pericardial effusion—Epirubicin—urinary bladder cancer	0.00699	0.0125	CcSEcCtD
Lisuride—Pulmonary fibrosis—Methotrexate—urinary bladder cancer	0.00697	0.0125	CcSEcCtD
Lisuride—Infection—Carboplatin—urinary bladder cancer	0.00675	0.0121	CcSEcCtD
Lisuride—ADRA2A—prostate gland—urinary bladder cancer	0.0067	0.0151	CbGeAlD
Lisuride—Pericarditis—Epirubicin—urinary bladder cancer	0.00663	0.0119	CcSEcCtD
Lisuride—HTR1A—renal system—urinary bladder cancer	0.00652	0.0147	CbGeAlD
Lisuride—Pericardial effusion—Doxorubicin—urinary bladder cancer	0.00647	0.0116	CcSEcCtD
Lisuride—HTR1B—female reproductive system—urinary bladder cancer	0.00647	0.0146	CbGeAlD
Lisuride—HTR1D—female reproductive system—urinary bladder cancer	0.00626	0.0142	CbGeAlD
Lisuride—HTR2C—female reproductive system—urinary bladder cancer	0.0062	0.014	CbGeAlD
Lisuride—Pericarditis—Doxorubicin—urinary bladder cancer	0.00614	0.011	CcSEcCtD
Lisuride—ADRB1—female reproductive system—urinary bladder cancer	0.00608	0.0138	CbGeAlD
Lisuride—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00605	0.0108	CcSEcCtD
Lisuride—HTR2B—female reproductive system—urinary bladder cancer	0.00582	0.0132	CbGeAlD
Lisuride—ADRA2C—renal system—urinary bladder cancer	0.00572	0.0129	CbGeAlD
Lisuride—ADRA2A—seminal vesicle—urinary bladder cancer	0.00567	0.0128	CbGeAlD
Lisuride—ADRA2C—urethra—urinary bladder cancer	0.00562	0.0127	CbGeAlD
Lisuride—Syncope—Mitomycin—urinary bladder cancer	0.00555	0.00996	CcSEcCtD
Lisuride—Cough—Mitomycin—urinary bladder cancer	0.0054	0.00969	CcSEcCtD
Lisuride—HTR2B—vagina—urinary bladder cancer	0.00527	0.0119	CbGeAlD
Lisuride—Asthenia—Valrubicin—urinary bladder cancer	0.00526	0.00944	CcSEcCtD
Lisuride—Confusional state—Mitomycin—urinary bladder cancer	0.0051	0.00914	CcSEcCtD
Lisuride—Dizziness—Valrubicin—urinary bladder cancer	0.00485	0.0087	CcSEcCtD
Lisuride—Anorexia—Mitomycin—urinary bladder cancer	0.00482	0.00864	CcSEcCtD
Lisuride—Dehydration—Thiotepa—urinary bladder cancer	0.00481	0.00863	CcSEcCtD
Lisuride—Disorientation—Fluorouracil—urinary bladder cancer	0.00478	0.00858	CcSEcCtD
Lisuride—Vomiting—Valrubicin—urinary bladder cancer	0.00467	0.00837	CcSEcCtD
Lisuride—Headache—Valrubicin—urinary bladder cancer	0.0046	0.00824	CcSEcCtD
Lisuride—Dyspnoea—Mitomycin—urinary bladder cancer	0.00451	0.00808	CcSEcCtD
Lisuride—Somnolence—Mitomycin—urinary bladder cancer	0.00449	0.00806	CcSEcCtD
Lisuride—ADRA2A—urethra—urinary bladder cancer	0.00449	0.0101	CbGeAlD
Lisuride—Decreased appetite—Mitomycin—urinary bladder cancer	0.00439	0.00788	CcSEcCtD
Lisuride—Fatigue—Mitomycin—urinary bladder cancer	0.00436	0.00782	CcSEcCtD
Lisuride—HTR2A—epithelium—urinary bladder cancer	0.00419	0.00946	CbGeAlD
Lisuride—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00417	0.00747	CcSEcCtD
Lisuride—ADRA2C—vagina—urinary bladder cancer	0.00415	0.00937	CbGeAlD
Lisuride—Weight increased—Thiotepa—urinary bladder cancer	0.00407	0.0073	CcSEcCtD
Lisuride—HTR2A—smooth muscle tissue—urinary bladder cancer	0.00403	0.00912	CbGeAlD
Lisuride—Pleural effusion—Methotrexate—urinary bladder cancer	0.004	0.00718	CcSEcCtD
Lisuride—HTR2A—renal system—urinary bladder cancer	0.00388	0.00878	CbGeAlD
Lisuride—Dehydration—Cisplatin—urinary bladder cancer	0.00377	0.00676	CcSEcCtD
Lisuride—Pleural effusion—Epirubicin—urinary bladder cancer	0.00375	0.00672	CcSEcCtD
Lisuride—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.0037	0.00664	CcSEcCtD
Lisuride—ADRA2A—female reproductive system—urinary bladder cancer	0.00366	0.00827	CbGeAlD
Lisuride—Asthenia—Mitomycin—urinary bladder cancer	0.00363	0.0065	CcSEcCtD
Lisuride—CYP3A4—renal system—urinary bladder cancer	0.0036	0.00813	CbGeAlD
Lisuride—Hallucination—Thiotepa—urinary bladder cancer	0.00356	0.00638	CcSEcCtD
Lisuride—CYP2D6—renal system—urinary bladder cancer	0.00354	0.008	CbGeAlD
Lisuride—Pleural effusion—Doxorubicin—urinary bladder cancer	0.00347	0.00622	CcSEcCtD
Lisuride—HTR2B—lymph node—urinary bladder cancer	0.00341	0.0077	CbGeAlD
Lisuride—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.00336	0.00603	CcSEcCtD
Lisuride—Dizziness—Mitomycin—urinary bladder cancer	0.00334	0.00599	CcSEcCtD
Lisuride—Cardiac disorder—Thiotepa—urinary bladder cancer	0.00332	0.00595	CcSEcCtD
Lisuride—ADRA2A—vagina—urinary bladder cancer	0.00331	0.00748	CbGeAlD
Lisuride—Angiopathy—Thiotepa—urinary bladder cancer	0.00325	0.00582	CcSEcCtD
Lisuride—Immune system disorder—Thiotepa—urinary bladder cancer	0.00323	0.0058	CcSEcCtD
Lisuride—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.00322	0.00578	CcSEcCtD
Lisuride—Sweating—Gemcitabine—urinary bladder cancer	0.00321	0.00576	CcSEcCtD
Lisuride—Vomiting—Mitomycin—urinary bladder cancer	0.00321	0.00576	CcSEcCtD
Lisuride—Headache—Mitomycin—urinary bladder cancer	0.00317	0.00568	CcSEcCtD
Lisuride—Mental disorder—Thiotepa—urinary bladder cancer	0.00313	0.00562	CcSEcCtD
Lisuride—Malnutrition—Thiotepa—urinary bladder cancer	0.00311	0.00559	CcSEcCtD
Lisuride—HTR2A—female reproductive system—urinary bladder cancer	0.00311	0.00703	CbGeAlD
Lisuride—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.00297	0.00532	CcSEcCtD
Lisuride—CYP3A4—female reproductive system—urinary bladder cancer	0.00288	0.00651	CbGeAlD
Lisuride—CYP2D6—female reproductive system—urinary bladder cancer	0.00283	0.0064	CbGeAlD
Lisuride—HTR2A—vagina—urinary bladder cancer	0.00281	0.00636	CbGeAlD
Lisuride—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00279	0.00501	CcSEcCtD
Lisuride—Angiopathy—Gemcitabine—urinary bladder cancer	0.00273	0.0049	CcSEcCtD
Lisuride—Immune system disorder—Gemcitabine—urinary bladder cancer	0.00272	0.00488	CcSEcCtD
Lisuride—Cough—Thiotepa—urinary bladder cancer	0.00272	0.00487	CcSEcCtD
Lisuride—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.00271	0.00486	CcSEcCtD
Lisuride—ADRA2C—lymph node—urinary bladder cancer	0.00268	0.00606	CbGeAlD
Lisuride—Anxiety—Thiotepa—urinary bladder cancer	0.00264	0.00474	CcSEcCtD
Lisuride—Cardiac disorder—Cisplatin—urinary bladder cancer	0.0026	0.00467	CcSEcCtD
Lisuride—Confusional state—Thiotepa—urinary bladder cancer	0.00256	0.0046	CcSEcCtD
Lisuride—Immune system disorder—Cisplatin—urinary bladder cancer	0.00253	0.00454	CcSEcCtD
Lisuride—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.00253	0.00453	CcSEcCtD
Lisuride—Infection—Thiotepa—urinary bladder cancer	0.00253	0.00453	CcSEcCtD
Lisuride—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00249	0.00447	CcSEcCtD
Lisuride—Tachycardia—Thiotepa—urinary bladder cancer	0.00248	0.00445	CcSEcCtD
Lisuride—Malnutrition—Cisplatin—urinary bladder cancer	0.00244	0.00438	CcSEcCtD
Lisuride—Anorexia—Thiotepa—urinary bladder cancer	0.00242	0.00435	CcSEcCtD
Lisuride—Cardiac disorder—Etoposide—urinary bladder cancer	0.00239	0.00428	CcSEcCtD
Lisuride—Angiopathy—Etoposide—urinary bladder cancer	0.00233	0.00418	CcSEcCtD
Lisuride—Immune system disorder—Etoposide—urinary bladder cancer	0.00232	0.00416	CcSEcCtD
Lisuride—Mediastinal disorder—Etoposide—urinary bladder cancer	0.00232	0.00415	CcSEcCtD
Lisuride—Cough—Gemcitabine—urinary bladder cancer	0.00229	0.0041	CcSEcCtD
Lisuride—Somnolence—Thiotepa—urinary bladder cancer	0.00226	0.00405	CcSEcCtD
Lisuride—Decreased appetite—Thiotepa—urinary bladder cancer	0.00221	0.00396	CcSEcCtD
Lisuride—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00219	0.00394	CcSEcCtD
Lisuride—Fatigue—Thiotepa—urinary bladder cancer	0.00219	0.00393	CcSEcCtD
Lisuride—Constipation—Thiotepa—urinary bladder cancer	0.00217	0.0039	CcSEcCtD
Lisuride—ADRA2A—lymph node—urinary bladder cancer	0.00214	0.00484	CbGeAlD
Lisuride—Infection—Gemcitabine—urinary bladder cancer	0.00212	0.00381	CcSEcCtD
Lisuride—Confusional state—Fluorouracil—urinary bladder cancer	0.00212	0.0038	CcSEcCtD
Lisuride—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.0021	0.00376	CcSEcCtD
Lisuride—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00209	0.00376	CcSEcCtD
Lisuride—Infection—Fluorouracil—urinary bladder cancer	0.00209	0.00375	CcSEcCtD
Lisuride—Anxiety—Cisplatin—urinary bladder cancer	0.00207	0.00372	CcSEcCtD
Lisuride—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00207	0.00371	CcSEcCtD
Lisuride—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00206	0.0037	CcSEcCtD
Lisuride—Tachycardia—Fluorouracil—urinary bladder cancer	0.00205	0.00368	CcSEcCtD
Lisuride—Anorexia—Gemcitabine—urinary bladder cancer	0.00204	0.00366	CcSEcCtD
Lisuride—Vertigo—Etoposide—urinary bladder cancer	0.00201	0.0036	CcSEcCtD
Lisuride—Anorexia—Fluorouracil—urinary bladder cancer	0.002	0.00359	CcSEcCtD
Lisuride—Infection—Cisplatin—urinary bladder cancer	0.00198	0.00355	CcSEcCtD
Lisuride—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00195	0.00351	CcSEcCtD
Lisuride—Cough—Etoposide—urinary bladder cancer	0.00195	0.0035	CcSEcCtD
Lisuride—Tachycardia—Cisplatin—urinary bladder cancer	0.00195	0.00349	CcSEcCtD
Lisuride—Dehydration—Epirubicin—urinary bladder cancer	0.00194	0.00347	CcSEcCtD
Lisuride—Insomnia—Gemcitabine—urinary bladder cancer	0.00193	0.00347	CcSEcCtD
Lisuride—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00193	0.00346	CcSEcCtD
Lisuride—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00191	0.00342	CcSEcCtD
Lisuride—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.0019	0.00341	CcSEcCtD
Lisuride—Insomnia—Fluorouracil—urinary bladder cancer	0.0019	0.00341	CcSEcCtD
Lisuride—Somnolence—Gemcitabine—urinary bladder cancer	0.0019	0.00341	CcSEcCtD
Lisuride—Anorexia—Cisplatin—urinary bladder cancer	0.0019	0.00341	CcSEcCtD
Lisuride—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00187	0.00336	CcSEcCtD
Lisuride—Somnolence—Fluorouracil—urinary bladder cancer	0.00187	0.00335	CcSEcCtD
Lisuride—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00186	0.00333	CcSEcCtD
Lisuride—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00185	0.00331	CcSEcCtD
Lisuride—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00184	0.00331	CcSEcCtD
Lisuride—Fatigue—Gemcitabine—urinary bladder cancer	0.00184	0.00331	CcSEcCtD
Lisuride—Confusional state—Etoposide—urinary bladder cancer	0.00184	0.0033	CcSEcCtD
Lisuride—Constipation—Gemcitabine—urinary bladder cancer	0.00183	0.00328	CcSEcCtD
Lisuride—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00183	0.00328	CcSEcCtD
Lisuride—Asthenia—Thiotepa—urinary bladder cancer	0.00182	0.00327	CcSEcCtD
Lisuride—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00182	0.00326	CcSEcCtD
Lisuride—Infection—Etoposide—urinary bladder cancer	0.00181	0.00325	CcSEcCtD
Lisuride—Dehydration—Doxorubicin—urinary bladder cancer	0.00179	0.00321	CcSEcCtD
Lisuride—Tachycardia—Etoposide—urinary bladder cancer	0.00178	0.0032	CcSEcCtD
Lisuride—Dyspnoea—Cisplatin—urinary bladder cancer	0.00178	0.00319	CcSEcCtD
Lisuride—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00177	0.00317	CcSEcCtD
Lisuride—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00176	0.00316	CcSEcCtD
Lisuride—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00176	0.00316	CcSEcCtD
Lisuride—Anorexia—Etoposide—urinary bladder cancer	0.00174	0.00312	CcSEcCtD
Lisuride—Decreased appetite—Cisplatin—urinary bladder cancer	0.00173	0.00311	CcSEcCtD
Lisuride—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00173	0.00311	CcSEcCtD
Lisuride—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00172	0.00309	CcSEcCtD
Lisuride—Dizziness—Thiotepa—urinary bladder cancer	0.00168	0.00301	CcSEcCtD
Lisuride—Sweating—Methotrexate—urinary bladder cancer	0.00164	0.00295	CcSEcCtD
Lisuride—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00164	0.00295	CcSEcCtD
Lisuride—Weight increased—Epirubicin—urinary bladder cancer	0.00164	0.00294	CcSEcCtD
Lisuride—Weight decreased—Epirubicin—urinary bladder cancer	0.00163	0.00292	CcSEcCtD
Lisuride—Dyspnoea—Etoposide—urinary bladder cancer	0.00163	0.00292	CcSEcCtD
Lisuride—Somnolence—Etoposide—urinary bladder cancer	0.00162	0.00291	CcSEcCtD
Lisuride—Vomiting—Thiotepa—urinary bladder cancer	0.00162	0.0029	CcSEcCtD
Lisuride—Headache—Thiotepa—urinary bladder cancer	0.00159	0.00286	CcSEcCtD
Lisuride—Decreased appetite—Etoposide—urinary bladder cancer	0.00159	0.00285	CcSEcCtD
Lisuride—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00158	0.00283	CcSEcCtD
Lisuride—Fatigue—Etoposide—urinary bladder cancer	0.00157	0.00282	CcSEcCtD
Lisuride—Constipation—Etoposide—urinary bladder cancer	0.00156	0.0028	CcSEcCtD
Lisuride—Sweating—Epirubicin—urinary bladder cancer	0.00154	0.00276	CcSEcCtD
Lisuride—Asthenia—Gemcitabine—urinary bladder cancer	0.00153	0.00275	CcSEcCtD
Lisuride—Weight increased—Doxorubicin—urinary bladder cancer	0.00152	0.00272	CcSEcCtD
Lisuride—Weight decreased—Doxorubicin—urinary bladder cancer	0.00151	0.0027	CcSEcCtD
Lisuride—Feeling abnormal—Etoposide—urinary bladder cancer	0.0015	0.0027	CcSEcCtD
Lisuride—Asthenia—Cisplatin—urinary bladder cancer	0.00143	0.00256	CcSEcCtD
Lisuride—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00143	0.00256	CcSEcCtD
Lisuride—Sweating—Doxorubicin—urinary bladder cancer	0.00142	0.00255	CcSEcCtD
Lisuride—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00142	0.00255	CcSEcCtD
Lisuride—Angiopathy—Methotrexate—urinary bladder cancer	0.0014	0.0025	CcSEcCtD
Lisuride—Immune system disorder—Methotrexate—urinary bladder cancer	0.00139	0.00249	CcSEcCtD
Lisuride—Dizziness—Fluorouracil—urinary bladder cancer	0.00139	0.00249	CcSEcCtD
Lisuride—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00139	0.00249	CcSEcCtD
Lisuride—Vomiting—Gemcitabine—urinary bladder cancer	0.00136	0.00244	CcSEcCtD
Lisuride—Mental disorder—Methotrexate—urinary bladder cancer	0.00135	0.00242	CcSEcCtD
Lisuride—Malnutrition—Methotrexate—urinary bladder cancer	0.00134	0.0024	CcSEcCtD
Lisuride—Headache—Gemcitabine—urinary bladder cancer	0.00134	0.0024	CcSEcCtD
Lisuride—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00134	0.0024	CcSEcCtD
Lisuride—Vomiting—Fluorouracil—urinary bladder cancer	0.00134	0.0024	CcSEcCtD
Lisuride—Headache—Fluorouracil—urinary bladder cancer	0.00132	0.00236	CcSEcCtD
Lisuride—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00131	0.00235	CcSEcCtD
Lisuride—Asthenia—Etoposide—urinary bladder cancer	0.00131	0.00235	CcSEcCtD
Lisuride—Angiopathy—Epirubicin—urinary bladder cancer	0.00131	0.00234	CcSEcCtD
Lisuride—Immune system disorder—Epirubicin—urinary bladder cancer	0.0013	0.00233	CcSEcCtD
Lisuride—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.0013	0.00233	CcSEcCtD
Lisuride—Vomiting—Cisplatin—urinary bladder cancer	0.00127	0.00227	CcSEcCtD
Lisuride—Mental disorder—Epirubicin—urinary bladder cancer	0.00126	0.00226	CcSEcCtD
Lisuride—Malnutrition—Epirubicin—urinary bladder cancer	0.00125	0.00225	CcSEcCtD
Lisuride—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00124	0.00222	CcSEcCtD
Lisuride—Angiopathy—Doxorubicin—urinary bladder cancer	0.00121	0.00217	CcSEcCtD
Lisuride—Dizziness—Etoposide—urinary bladder cancer	0.00121	0.00217	CcSEcCtD
Lisuride—Immune system disorder—Doxorubicin—urinary bladder cancer	0.0012	0.00216	CcSEcCtD
Lisuride—Vertigo—Methotrexate—urinary bladder cancer	0.0012	0.00216	CcSEcCtD
Lisuride—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.0012	0.00215	CcSEcCtD
Lisuride—Cough—Methotrexate—urinary bladder cancer	0.00117	0.0021	CcSEcCtD
Lisuride—Mental disorder—Doxorubicin—urinary bladder cancer	0.00117	0.00209	CcSEcCtD
Lisuride—Vomiting—Etoposide—urinary bladder cancer	0.00116	0.00208	CcSEcCtD
Lisuride—Malnutrition—Doxorubicin—urinary bladder cancer	0.00116	0.00208	CcSEcCtD
Lisuride—Headache—Etoposide—urinary bladder cancer	0.00114	0.00205	CcSEcCtD
Lisuride—Vertigo—Epirubicin—urinary bladder cancer	0.00113	0.00202	CcSEcCtD
Lisuride—Syncope—Epirubicin—urinary bladder cancer	0.00112	0.00202	CcSEcCtD
Lisuride—Palpitations—Epirubicin—urinary bladder cancer	0.00111	0.00199	CcSEcCtD
Lisuride—Confusional state—Methotrexate—urinary bladder cancer	0.0011	0.00198	CcSEcCtD
Lisuride—Cough—Epirubicin—urinary bladder cancer	0.00109	0.00196	CcSEcCtD
Lisuride—Infection—Methotrexate—urinary bladder cancer	0.00109	0.00195	CcSEcCtD
Lisuride—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00107	0.00192	CcSEcCtD
Lisuride—Anxiety—Epirubicin—urinary bladder cancer	0.00106	0.00191	CcSEcCtD
Lisuride—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00106	0.0019	CcSEcCtD
Lisuride—Dry mouth—Epirubicin—urinary bladder cancer	0.00104	0.00187	CcSEcCtD
Lisuride—Vertigo—Doxorubicin—urinary bladder cancer	0.00104	0.00187	CcSEcCtD
Lisuride—Anorexia—Methotrexate—urinary bladder cancer	0.00104	0.00187	CcSEcCtD
Lisuride—Syncope—Doxorubicin—urinary bladder cancer	0.00104	0.00187	CcSEcCtD
Lisuride—Confusional state—Epirubicin—urinary bladder cancer	0.00103	0.00185	CcSEcCtD
Lisuride—Palpitations—Doxorubicin—urinary bladder cancer	0.00103	0.00184	CcSEcCtD
Lisuride—Infection—Epirubicin—urinary bladder cancer	0.00102	0.00182	CcSEcCtD
Lisuride—Cough—Doxorubicin—urinary bladder cancer	0.00101	0.00182	CcSEcCtD
Lisuride—Nervous system disorder—Epirubicin—urinary bladder cancer	0.001	0.0018	CcSEcCtD
Lisuride—Tachycardia—Epirubicin—urinary bladder cancer	0.000999	0.00179	CcSEcCtD
Lisuride—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00099	0.00177	CcSEcCtD
Lisuride—Insomnia—Methotrexate—urinary bladder cancer	0.000989	0.00177	CcSEcCtD
Lisuride—Anxiety—Doxorubicin—urinary bladder cancer	0.000985	0.00177	CcSEcCtD
Lisuride—Anorexia—Epirubicin—urinary bladder cancer	0.000976	0.00175	CcSEcCtD
Lisuride—Dyspnoea—Methotrexate—urinary bladder cancer	0.000975	0.00175	CcSEcCtD
Lisuride—Somnolence—Methotrexate—urinary bladder cancer	0.000972	0.00174	CcSEcCtD
Lisuride—Dry mouth—Doxorubicin—urinary bladder cancer	0.000966	0.00173	CcSEcCtD
Lisuride—Confusional state—Doxorubicin—urinary bladder cancer	0.000955	0.00171	CcSEcCtD
Lisuride—Decreased appetite—Methotrexate—urinary bladder cancer	0.000951	0.00171	CcSEcCtD
Lisuride—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000944	0.00169	CcSEcCtD
Lisuride—Fatigue—Methotrexate—urinary bladder cancer	0.000943	0.00169	CcSEcCtD
Lisuride—Infection—Doxorubicin—urinary bladder cancer	0.000941	0.00169	CcSEcCtD
Lisuride—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000929	0.00167	CcSEcCtD
Lisuride—Insomnia—Epirubicin—urinary bladder cancer	0.000926	0.00166	CcSEcCtD
Lisuride—Tachycardia—Doxorubicin—urinary bladder cancer	0.000924	0.00166	CcSEcCtD
Lisuride—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000916	0.00164	CcSEcCtD
Lisuride—Dyspnoea—Epirubicin—urinary bladder cancer	0.000913	0.00164	CcSEcCtD
Lisuride—Somnolence—Epirubicin—urinary bladder cancer	0.00091	0.00163	CcSEcCtD
Lisuride—Anorexia—Doxorubicin—urinary bladder cancer	0.000903	0.00162	CcSEcCtD
Lisuride—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000901	0.00162	CcSEcCtD
Lisuride—Decreased appetite—Epirubicin—urinary bladder cancer	0.00089	0.0016	CcSEcCtD
Lisuride—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000884	0.00158	CcSEcCtD
Lisuride—Fatigue—Epirubicin—urinary bladder cancer	0.000882	0.00158	CcSEcCtD
Lisuride—Constipation—Epirubicin—urinary bladder cancer	0.000875	0.00157	CcSEcCtD
Lisuride—Insomnia—Doxorubicin—urinary bladder cancer	0.000857	0.00154	CcSEcCtD
Lisuride—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000844	0.00151	CcSEcCtD
Lisuride—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000843	0.00151	CcSEcCtD
Lisuride—Somnolence—Doxorubicin—urinary bladder cancer	0.000842	0.00151	CcSEcCtD
Lisuride—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000823	0.00148	CcSEcCtD
Lisuride—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000818	0.00147	CcSEcCtD
Lisuride—Fatigue—Doxorubicin—urinary bladder cancer	0.000817	0.00146	CcSEcCtD
Lisuride—Constipation—Doxorubicin—urinary bladder cancer	0.00081	0.00145	CcSEcCtD
Lisuride—Asthenia—Methotrexate—urinary bladder cancer	0.000785	0.00141	CcSEcCtD
Lisuride—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00078	0.0014	CcSEcCtD
Lisuride—Asthenia—Epirubicin—urinary bladder cancer	0.000734	0.00132	CcSEcCtD
Lisuride—Dizziness—Methotrexate—urinary bladder cancer	0.000723	0.0013	CcSEcCtD
Lisuride—Vomiting—Methotrexate—urinary bladder cancer	0.000695	0.00125	CcSEcCtD
Lisuride—Headache—Methotrexate—urinary bladder cancer	0.000685	0.00123	CcSEcCtD
Lisuride—Asthenia—Doxorubicin—urinary bladder cancer	0.00068	0.00122	CcSEcCtD
Lisuride—Dizziness—Epirubicin—urinary bladder cancer	0.000677	0.00121	CcSEcCtD
Lisuride—Vomiting—Epirubicin—urinary bladder cancer	0.000651	0.00117	CcSEcCtD
Lisuride—Headache—Epirubicin—urinary bladder cancer	0.000641	0.00115	CcSEcCtD
Lisuride—Dizziness—Doxorubicin—urinary bladder cancer	0.000626	0.00112	CcSEcCtD
Lisuride—Vomiting—Doxorubicin—urinary bladder cancer	0.000602	0.00108	CcSEcCtD
Lisuride—Headache—Doxorubicin—urinary bladder cancer	0.000593	0.00106	CcSEcCtD
